Clavispora lusitaniae (named until 1996 Candida. (C.) lusitaniae) were emerging fungal organisms and the first cases of infection in humans were described.
The patient reported no menopausal vasomotor symptoms and was not taking hormone replacement therapy. Evaluation of follicle-stimulating hormone (FSH) and
1965 et 1995 la durée moyenne des symptômes avant prise en charge hospitalière était de 32 l'exception notable de Candida lusitaniae – mais la tolé-.
Candida tropicalis C. krusei
The patient reported no menopausal vasomotor symptoms and was not taking hormone replacement therapy. Evaluation of follicle-stimulating hormone (FSH) and
Candida lusitaniae. Les symptômes respiratoires vont de la pneumonie modérée à mortelle. Les infections du système nerveux central se traduisent par une ...
9 août 2018 Candida lusitaniae Aspergillus terreus
Objectives: The aim of the present study was to expand the MIC database for Candida lusitaniae in order to further determine its antifungal susceptibility
13 mai 1990 Candida lusitaniae an organism frequently resistant to amphotericin B. We ... species were isolated from a site without signs or symptoms.
7 déc. 2016 5.1.1 Souches de Candida lusitaniae utilisées et conditions de culture . ... gitation une insu sance cardiaque ou des symptômes en relation ...